Skip to main content
Premium Trial:

Request an Annual Quote

Paying Attention to Personalized Medicine

New York State Assemblyman Gary Pretlow has introduced a bill that would require insurance companies in New York to provide coverage for genetic testing for people who are deemed to be at risk for contracting cancer, reports Genomics Law Report's Dan Vorhaus. The bill would also require insurance companies to cover that individual for any treatments resulting from the results of such genetic tests. This is only a bill, and would require much more detail on types of genetic tests, venues and providers, and other issues before it has a chance of becoming a viable law, Vorhaus adds. But the bill also highlights the national problem the US still has with matters of genetic testing and personalized medicine. "While regulators and regulated companies struggle to make sense of the current landscape, genetic testing has garnered increasingly high-profile media and political attention in several areas," Vorhaus says. "As these issues remain unresolved ... the pressure on lawmakers to act continues to grow." What is needed is a total overhaul of the legal framework surrounding genetic testing for the whole country, he adds, and while proposals like Pretlow's try to deal with the problem at a local level, they merely amount to "band-aids."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.